2019
DOI: 10.1016/j.ejmech.2019.06.024
|View full text |Cite
|
Sign up to set email alerts
|

Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(28 citation statements)
references
References 31 publications
0
28
0
Order By: Relevance
“…In addition, highlighted compound 14 showed significant antitumor activity in mouse acute myeloid leukaemia (AML) models without producing apparent toxic effects in vivo. Additionally, among the synthesised compounds, the piperazine and methylpiperazine substituted derivatives exhibited higher antiproliferative potency against the HepG2 cell line, while morpholine and pyrrolidine substituted analogs showed dramatically lower antiproliferative activity 39 .…”
Section: Biological Effects Of Natural Products Containing the Piperazinyl Moietymentioning
confidence: 99%
“…In addition, highlighted compound 14 showed significant antitumor activity in mouse acute myeloid leukaemia (AML) models without producing apparent toxic effects in vivo. Additionally, among the synthesised compounds, the piperazine and methylpiperazine substituted derivatives exhibited higher antiproliferative potency against the HepG2 cell line, while morpholine and pyrrolidine substituted analogs showed dramatically lower antiproliferative activity 39 .…”
Section: Biological Effects Of Natural Products Containing the Piperazinyl Moietymentioning
confidence: 99%
“…Wogonin directly binds to the ATP-binding pocket of CDK9 (44). One of the wogonin derivatives was also noticed to be effective against CDK9 (45).…”
Section: Regulation Of Vegf/vegfr Signalingmentioning
confidence: 99%
“…The seminal discovery of flavopiridol (alvocidib) 1 (Figure . 1) whose structure was inspired by the natural antirheumatic flavonoid "Rohitukine" [19][20][21][22] led to the development of new synthetic flavonoids-based compounds as inhibitors of kinases. Alvocidib, the first CDKs (CDK1, 2,4,6,7,9) inhibitor to be tested in a clinical trial [23][24][25] is the most active CDK9 inhibitor with IC 50 value of 20 nM. This drug is capable to induce regluated cell death with a block in the cell cycle at the G1/S and G2/M phases.…”
Section: Figure 1 Flavopiridol and Mimics As Potent Cdks Inhibitorsmentioning
confidence: 99%
“…Particularly, in cancer diseases, flavonoids are known for their ability to inhibit important cell signaling proteins such as cyclin-dependent kinases (CDKs). [5][6][7] CDKs are wellknown to be the main key regulators of cell cycle progression, their hyperactivation is associated with several cancers.…”
Section: Introductionmentioning
confidence: 99%